Lenzilumab Uses, Dosage, Side Effects and more
Lenzilumab is under investigation in clinical trial NCT02546284 (Study of Lenzilumab in Previously Treated Patients With Chronic Myelomonocytic Leukemia (CMML)).
| Trade Name | Lenzilumab |
| Generic | Lenzilumab |
| Lenzilumab Other Names | Lenzilumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
